View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Johannes Grunselius
  • Johannes Grunselius

UPM (Buy, TP: EUR42.00) - Earnings growth and buybacks

Since UPM had pre-released Q3 EBIT and provided new Q4 guidance, the Q3 report included no real surprises. Still, we are encouraged by UPM’s focus on continuously reducing fixed costs. Based on improved volumes in combination with better prices for pulp and biofuels, we are confident UPM will show impressive earnings growth. Based on reduced 2025–2027e capex, we also expect strong free cash flow, leaving the balance sheet overcapitalised, and paving the way for buybacks on top of compelling divi...

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Magnus Andersson
  • Patrik Brattelius
Nicolas McBeath
  • Nicolas McBeath

Nordnet (Buy, TP: SEK255.00) - Several rate-cut mitigants in 2025e

We see plenty of growth drivers to mitigate the EPS drop in 2025e (given the likely rate cut headwinds), and restore Nordnet to >10% EPS growth in 2026e, including: the near-term launch of Livrente in Denmark, macro tailwinds for household savers, widening credit margins in loans and liquidity portfolios, and share buybacks. We have raised our 2025–2026e EPS by 1–2% and our target price to SEK255 (252), and reiterate our BUY.

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Magnus Andersson
  • Patrik Brattelius
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Jesper Ingildsen
  • Jesper Ingildsen

Embla Medical (Buy, TP: DKK39.00) - Momentum remains strong

Q3 organic revenue growth of c7% YOY was largely in line with expectations and at the high end of the long-term guidance of 5–7% despite end-market headwinds. We believe growth could strengthen further in 2025 and beyond, helped by the recent US Medicare expanded coverage. The Q3 report also showed the EBITDA margin continuing to improve faster than we expected. We reiterate our BUY and DKK39 target price.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Johannes Grunselius
  • Johannes Grunselius

UPM (Buy, TP: EUR42.00) - Still fit for growth and buybacks

Although we were surprised and disappointed by UPM’s 2024 profit warning, we remain confident that it will report strong earnings growth for 2025–2026. With incrementally higher profits from the new business in Uruguay and low 2025–2026e capex, we also expect strong free cash flow, leaving the balance sheet overcapitalised with 2025–2026e NIBD/EBITDA of 0.5–0.1x, paving the way for much-increased, value-accretive shareholder cash allocations. We reiterate our BUY but have cut our target price to...

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Nicolas McBeath
  • Nicolas McBeath

Nordnet (Buy, TP: SEK252.00) - Starting the shift away from NII

Q3 looks set to mark the start of a 4-quarter trend of falling NII. Nevertheless, our long-term structural growth case is intact and we expect rising commissions to have compensated for most of the NII decline by 2026e. We reiterate our BUY but have lowered our target price to SEK252 (256), having reduced our 2025–2026e PTP by c4%, mainly on lower NII.

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Magnus Andersson
  • Patrik Brattelius
ABGSC Online Gaming Research ... (+3)
  • ABGSC Online Gaming Research
  • Oscar Rönnkvist
  • Simon Jönsson
ABGSC Online Gaming Research ... (+3)
  • ABGSC Online Gaming Research
  • Oscar Rönnkvist
  • Simon Jönsson
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch